| Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. | |
MedLine Citation:
|
PMID: 9329379 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Hypothyroidism is frequently associated with hypercholesterolemia and an increased risk for atherosclerosis, whereas hyperthyroidism is known to precipitate angina or myocardial infarction in patients with underlying coronary heart disease. We have shown previously that L-T4 functions as an antioxidant in vitro and inhibits low density lipoprotein (LDL) oxidation in a dose-dependent fashion. The present study was designed to evaluate the changes in LDL oxidation in subjects with hypothyroidism and hyperthyroidism. Fasting blood samples for LDL oxidation analyses, lipoprotein determinations, and thyroid function tests were collected at baseline and after the patients were rendered euthyroid. The lag phase (mean +/- SEM hours) of the Cu+2-catalyzed LDL oxidation in the hypothyroid state and the subsequent euthyroid states were 4 +/- 0.0.65 and 14 +/- 0.68 h, respectively (P < 0.05). The lag phase during the hyperthyroid phase was 6 +/- 0.55 h, and that during the euthyroid phase was 12 +/- 0.66 h (P < 0.05). The total and LDL cholesterol levels were higher in hypothyroidism than in euthyroidism and were lower in hyperthyroidism than in the euthyroid state. We conclude that LDL has more susceptibility to oxidation in both the hypothyroid and hyperthyroid states. Thus, the enhanced LDL oxidation may play a role in the cardiac disease process in both hypothyroidism and hyperthyroidism. |
Authors:
|
V Sundaram; A N Hanna; L Koneru; H A Newman; J M Falko |
Related Documents
:
|
15159039 - A comparison of hdl and ldl cholesterol for prevalent coronary calcification. 18417069 - Adjunctive interventions in myocardial infarction: the role of statin therapy. 24217829 - A less aggressive therapeutic option for electrical storm. 12397569 - Low serum total cholesterol is associated with marked increase in mortality in advanced... 9856919 - Cost-effectiveness of statins. 15690309 - Fibrinogen and other coronary risk factors. 1719499 - Orthodromic and antidromic pacemaker circus movement tachycardia. 18941649 - Low incidence of neurologic events during long-term support with the heartmate xve left... 7246449 - Clinical, electrocardiographic and follow-up observations in patients having ventricula... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The Journal of clinical endocrinology and metabolism Volume: 82 ISSN: 0021-972X ISO Abbreviation: J. Clin. Endocrinol. Metab. Publication Date: 1997 Oct |
Date Detail:
|
Created Date: 1997-11-17 Completed Date: 1997-11-17 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0375362 Medline TA: J Clin Endocrinol Metab Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 3421-4 Citation Subset: AIM; IM |
Affiliation:
|
Department of Internal Medicine, Ohio State University, Columbus 43210, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Copper / pharmacology Drug Resistance Female Humans Hyperthyroidism / blood* Hypothyroidism / blood* Lipoproteins / blood Lipoproteins, LDL / blood* Male Middle Aged Oxidation-Reduction Reference Values Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Lipoproteins; 0/Lipoproteins, LDL; 7440-50-8/Copper |
| Comments/Corrections | |
Comment In:
|
J Clin Endocrinol Metab. 1998 Sep;83(9):3377-8
[PMID:
9745459
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hyp...
Next Document: Raloxifene and estrogen: comparative bone-remodeling kinetics.